|
GB0603683D0
(en)
*
|
2006-02-23 |
2006-04-05 |
Novartis Ag |
Organic compounds
|
|
AR064333A1
(es)
|
2006-12-14 |
2009-04-01 |
Schering Corp |
Anticuerpo anti-tslp de diseno
|
|
EP2803675A3
(en)
|
2008-01-25 |
2014-12-24 |
Amgen, Inc |
Ferroportin antibodies and methods of use
|
|
EP3594356A1
(en)
*
|
2009-11-04 |
2020-01-15 |
Merck Sharp & Dohme Corp. |
Engineered anti-tslp antibody
|
|
CA2885176C
(en)
*
|
2010-09-22 |
2018-10-23 |
Amgen Inc. |
Carrier immunoglobulins and uses thereof
|
|
EP2773774A4
(en)
*
|
2011-11-03 |
2015-06-10 |
Merck Sharp & Dohme |
BIOMARKERS FOR TSLP TREATMENT
|
|
CN104507968B
(zh)
*
|
2012-04-27 |
2019-02-05 |
诺和诺德股份有限公司 |
人cd30配体抗原结合蛋白
|
|
UY35148A
(es)
|
2012-11-21 |
2014-05-30 |
Amgen Inc |
Immunoglobulinas heterodiméricas
|
|
WO2014144817A2
(en)
|
2013-03-15 |
2014-09-18 |
Amgen Inc. |
Inhibitory polypeptides specific to wnt inhibitors
|
|
CN104371019B
(zh)
*
|
2013-08-13 |
2019-09-10 |
鸿运华宁（杭州）生物医药有限公司 |
一种能与glp-1r特异性结合的抗体及其与glp-1的融合蛋白质
|
|
TW201605896A
(zh)
|
2013-08-30 |
2016-02-16 |
安美基股份有限公司 |
Gitr抗原結合蛋白
|
|
EP3712166A1
(en)
|
2013-09-05 |
2020-09-23 |
Amgen Inc. |
Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profiles
|
|
WO2015118124A1
(en)
*
|
2014-02-06 |
2015-08-13 |
Vib Vzw |
Thymic stromal lymphopoietin receptor antagonist
|
|
SG11201609219QA
(en)
|
2014-05-07 |
2016-12-29 |
Amgen Inc |
Autoinjector with shock reducing elements
|
|
WO2015175861A1
(en)
|
2014-05-16 |
2015-11-19 |
Amgen Inc. |
Assay for detecting th1 and th2 cell populations
|
|
US20170103186A1
(en)
|
2014-06-03 |
2017-04-13 |
Amgen Inc. |
Systems and methods for supporting patient use of a drug delivery device
|
|
ES3056224T3
(en)
|
2014-10-14 |
2026-02-19 |
Amgen Inc |
Drug injection device with visual and audible indicators
|
|
ES2964713T3
(es)
|
2014-10-23 |
2024-04-09 |
Amgen Inc |
Reducción de la viscosidad de formulaciones farmacéuticas
|
|
EP3689394A1
(en)
|
2014-12-19 |
2020-08-05 |
Amgen Inc. |
Drug delivery device with live button or user interface field
|
|
US10583245B2
(en)
|
2015-02-17 |
2020-03-10 |
Amgen Inc. |
Drug delivery device with vacuum assisted securement and/or feedback
|
|
ES2905870T3
(es)
|
2015-02-27 |
2022-04-12 |
Amgen Inc |
Dispositivo de suministro de fármacos que tiene un mecanismo de protección de aguja con un umbral de resistencia ajustable al movimiento de la protección de aguja
|
|
CN107428828A
(zh)
*
|
2015-03-11 |
2017-12-01 |
葛兰素史密斯克莱知识产权发展有限公司 |
Tslp结合蛋白
|
|
EP3297672B1
(en)
*
|
2015-05-21 |
2021-09-01 |
Harpoon Therapeutics, Inc. |
Trispecific binding proteins and methods of use
|
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
|
EA038332B1
(ru)
*
|
2015-09-09 |
2021-08-10 |
Новартис Аг |
Молекулы, связывающиеся с тимусным стромальным лимфопоэтином (tslp), и способы применения таких молекул
|
|
EP3842457A1
(en)
|
2015-09-09 |
2021-06-30 |
Novartis AG |
Thymic stromal lymphopoietin (tslp)-binding molecules and methods of using the molecules
|
|
JP7082568B2
(ja)
|
2015-12-09 |
2022-06-08 |
アムジエン・インコーポレーテツド |
信号伝達キャップ付き自動注射器
|
|
WO2017120178A1
(en)
|
2016-01-06 |
2017-07-13 |
Amgen Inc. |
Auto-injector with signaling electronics
|
|
US10053515B2
(en)
|
2016-01-22 |
2018-08-21 |
Merck Sharp & Dohme Corp. |
Anti-coagulation factor XI antibodies
|
|
GB201615588D0
(en)
*
|
2016-09-14 |
2016-10-26 |
Glaxosmithkline Ip Dev Ltd |
TSLP Binding Proteins
|
|
WO2017160799A1
(en)
|
2016-03-15 |
2017-09-21 |
Amgen Inc. |
Reducing probability of glass breakage in drug delivery devices
|
|
US11001624B2
(en)
*
|
2016-04-05 |
2021-05-11 |
Vib Vzw |
TSLP inhibitors
|
|
WO2017189089A1
(en)
|
2016-04-29 |
2017-11-02 |
Amgen Inc. |
Drug delivery device with messaging label
|
|
US11389588B2
(en)
|
2016-05-02 |
2022-07-19 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
|
MX2018013616A
(es)
|
2016-05-13 |
2019-02-21 |
Amgen Inc |
Montaje de cubierta protectora de vial.
|
|
WO2017200989A1
(en)
|
2016-05-16 |
2017-11-23 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
|
KR102530742B1
(ko)
|
2016-05-20 |
2023-05-09 |
하푼 테라퓨틱스, 인크. |
단일 도메인 혈청 알부민 결합 단백질
|
|
ES3066292T3
(en)
|
2016-06-03 |
2026-05-12 |
Amgen Inc |
Impact testing apparatuses and methods for drug delivery devices
|
|
EA201892716A1
(ru)
|
2016-06-14 |
2019-05-31 |
Мерк Шарп И Доум Корп. |
Антитела к фактору свертывания xi
|
|
EP3478342B1
(en)
|
2016-07-01 |
2025-03-12 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
|
RU2721582C1
(ru)
*
|
2016-08-05 |
2020-05-20 |
И-Байолоджикс Инк. |
Антитела против лиганда-1 запрограммированной смерти (PD-L1) и их применение
|
|
US20190328965A1
(en)
|
2016-08-17 |
2019-10-31 |
Amgen Inc. |
Drug delivery device with placement detection
|
|
EP3532127B1
(en)
|
2016-10-25 |
2026-04-08 |
Amgen Inc. |
On-body injector
|
|
TWI784988B
(zh)
|
2016-12-01 |
2022-12-01 |
美商再生元醫藥公司 |
治療發炎症狀的方法
|
|
WO2018136398A1
(en)
|
2017-01-17 |
2018-07-26 |
Amgen Inc. |
Injection devices and related methods of use and assembly
|
|
CA3045376C
(en)
*
|
2017-01-24 |
2022-08-30 |
I-Mab |
Anti-cd73 antibodies and uses thereof
|
|
MX2019009755A
(es)
|
2017-02-17 |
2019-10-07 |
Amgen Inc |
Mecanismo de insercion para dispositivo de suministro de farmacos.
|
|
AU2018220538B2
(en)
|
2017-02-17 |
2023-12-14 |
Amgen Inc. |
Drug delivery device with sterile fluid flowpath and related method of assembly
|
|
JP7377596B2
(ja)
|
2017-02-22 |
2023-11-10 |
アムジエン・インコーポレーテツド |
低粘度、高濃度エボロクマブ製剤及びそれらの製造方法
|
|
WO2018165143A1
(en)
|
2017-03-06 |
2018-09-13 |
Amgen Inc. |
Drug delivery device with activation prevention feature
|
|
KR102627069B1
(ko)
|
2017-03-07 |
2024-01-18 |
암겐 인코포레이티드 |
과압에 의한 바늘 삽입
|
|
SG11201908062QA
(en)
|
2017-03-09 |
2019-09-27 |
Amgen Inc |
Insertion mechanism for drug delivery device
|
|
AU2018235928B2
(en)
|
2017-03-14 |
2023-09-21 |
Amgen Inc. |
Control of total afucosylated glycoforms of antibodies produced in cell culture
|
|
MX2019011416A
(es)
|
2017-03-28 |
2019-11-01 |
Amgen Inc |
Sistema y metodo para conjunto de jeringa y vastago de embolo.
|
|
EP3609917A1
(en)
|
2017-04-12 |
2020-02-19 |
Amgen Inc. |
Treatment of asthma with anti-tslp antibody
|
|
US12103979B2
(en)
|
2017-04-28 |
2024-10-01 |
Amgen Inc. |
N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides
|
|
AU2018280054B2
(en)
|
2017-06-08 |
2023-07-13 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
|
CA3066399A1
(en)
|
2017-06-08 |
2018-12-13 |
Amgen Inc. |
Torque driven drug delivery device
|
|
MA49447A
(fr)
|
2017-06-22 |
2020-04-29 |
Amgen Inc |
Réduction des impacts/chocs d'activation d'un dispositif
|
|
JP7475860B2
(ja)
|
2017-06-23 |
2024-04-30 |
アムジエン・インコーポレーテツド |
スイッチアセンブリにより起動されるキャップを含む電子薬物送達デバイス
|
|
CN109206514B
(zh)
*
|
2017-07-03 |
2019-10-08 |
拜西欧斯（北京）生物技术有限公司 |
Tslp单克隆抗体及其制备方法和应用
|
|
JP7408398B2
(ja)
|
2017-07-14 |
2024-01-05 |
アムジエン・インコーポレーテツド |
二重ねじりばねシステムを有する針挿入後退システム
|
|
JP7649105B2
(ja)
|
2017-07-21 |
2025-03-19 |
アムジエン・インコーポレーテツド |
薬物容器のためのガス透過性シーリング部材及び組立方法
|
|
WO2019022951A1
(en)
|
2017-07-25 |
2019-01-31 |
Amgen Inc. |
DRUG DELIVERY DEVICE WITH GEAR MODULE AND ASSEMBLY METHOD THEREOF
|
|
EP3658206A1
(en)
|
2017-07-25 |
2020-06-03 |
Amgen Inc. |
Drug delivery device with container access system and related method of assembly
|
|
BR112020001922A2
(pt)
|
2017-08-01 |
2020-08-04 |
Amgen Inc. |
sistemas e métodos para realização de um ensaio de glicanas em tempo real de uma amostra
|
|
EA202090399A1
(ru)
|
2017-08-01 |
2020-05-20 |
Эмджен Инк. |
Системы и способы для подготовки в режиме реального времени образца полипептида для анализа с помощью масс-спектрометрии
|
|
US12318593B2
(en)
|
2017-08-09 |
2025-06-03 |
Amgen Inc. |
Hydraulic-pneumatic pressurized chamber drug delivery system
|
|
EP3669004A1
(en)
|
2017-08-16 |
2020-06-24 |
Medimmune, LLC |
Compositions and methods for treatment of atopic dermatitis and treatment selection
|
|
EP3668567B1
(en)
|
2017-08-18 |
2026-02-18 |
Amgen Inc. |
Wearable injector with sterile adhesive patch
|
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
|
EP3691717B1
(en)
|
2017-10-04 |
2023-02-08 |
Amgen Inc. |
Flow adapter for drug delivery device
|
|
EP4257164A3
(en)
|
2017-10-06 |
2024-01-17 |
Amgen Inc. |
Drug delivery device with interlock assembly and related method of assembly
|
|
MA50348A
(fr)
|
2017-10-09 |
2020-08-19 |
Amgen Inc |
Dispositif d'administration de médicament comprenant un ensemble d'entraînement et procédé d'assemblage associé
|
|
IL315737A
(en)
|
2017-10-13 |
2024-11-01 |
Harpoon Therapeutics Inc |
B-cell maturation antigen-binding proteins
|
|
CA3078969A1
(en)
|
2017-10-13 |
2019-04-18 |
Harpoon Therapeutics, Inc. |
Trispecific proteins and methods of use
|
|
ES3069718T3
(en)
|
2017-11-03 |
2026-06-10 |
Amgen Inc |
System and approaches for sterilizing a drug delivery device
|
|
CA3079197A1
(en)
|
2017-11-06 |
2019-05-09 |
Amgen Inc. |
Drug delivery device with placement and flow sensing
|
|
MA50569A
(fr)
|
2017-11-06 |
2020-09-16 |
Amgen Inc |
Ensembles de remplissage-finition et procédés associés
|
|
IL319987A
(en)
|
2017-11-10 |
2025-06-01 |
Amgen Inc |
Plungers for drug delivery devices
|
|
AU2018368340B2
(en)
|
2017-11-16 |
2024-03-07 |
Amgen Inc. |
Door latch mechanism for drug delivery device
|
|
WO2019178280A1
(en)
|
2018-03-13 |
2019-09-19 |
Amgen Inc. |
Sequential digestion of polypeptides for mass spectrometric analysis
|
|
WO2019178151A1
(en)
|
2018-03-13 |
2019-09-19 |
Amgen Inc. |
Methods for the preparation of trypsin-resistant polypeptides for mass spectrometric analysis
|
|
US12325737B2
(en)
|
2018-03-26 |
2025-06-10 |
Amgen Inc. |
Total afucosylated glycoforms of antibodies produced in cell culture
|
|
MX2020012217A
(es)
|
2018-05-14 |
2021-03-02 |
Harpoon Therapeutics Inc |
Porción de unión para activación condicional de moléculas de inmunoglobulina.
|
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
|
US12303677B2
(en)
|
2018-07-24 |
2025-05-20 |
Amgen Inc. |
Hybrid drug delivery devices with optional grip portion and related method of preparation
|
|
CA3103682A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Delivery devices for administering drugs
|
|
CN112469454B
(zh)
|
2018-07-24 |
2024-01-26 |
安进公司 |
用于施用药物的输送装置
|
|
MA53320A
(fr)
|
2018-07-31 |
2021-11-03 |
Amgen Inc |
Ensemble de trajet de fluide pour dispositif d'administration de médicament
|
|
US12195544B2
(en)
|
2018-09-21 |
2025-01-14 |
Harpoon Therapeutics, Inc. |
EGFR binding proteins and methods of use
|
|
CA3106452A1
(en)
|
2018-09-24 |
2020-04-02 |
Amgen Inc. |
Interventional dosing systems and methods
|
|
CN119306844A
(zh)
|
2018-09-25 |
2025-01-14 |
哈普恩治疗公司 |
Dll3结合蛋白及使用方法
|
|
US12042642B2
(en)
|
2018-09-28 |
2024-07-23 |
Amgen Inc. |
Muscle wire escapement activation assembly for a drug delivery device
|
|
WO2020072577A1
(en)
|
2018-10-02 |
2020-04-09 |
Amgen Inc. |
Injection systems for drug delivery with internal force transmission
|
|
JP7547325B2
(ja)
|
2018-10-05 |
2024-09-09 |
アムジエン・インコーポレーテツド |
投薬量インジケータを有する薬物送達デバイス
|
|
JP7719714B2
(ja)
|
2018-10-15 |
2025-08-06 |
アムジエン・インコーポレーテツド |
ダンピング機構を有する薬物送達装置
|
|
MA53913A
(fr)
|
2018-10-15 |
2022-01-19 |
Amgen Inc |
Procédé d'assemblage de plate-forme pour dispositif d'administration de médicament
|
|
MA54057A
(fr)
|
2018-11-01 |
2022-02-09 |
Amgen Inc |
Dispositifs d'administration de médicament à rétraction partielle d'élément d'administration de médicament
|
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
|
WO2020091956A1
(en)
|
2018-11-01 |
2020-05-07 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
US12000775B2
(en)
|
2018-12-14 |
2024-06-04 |
Amgen Inc. |
System suitability method for use with protein concentration determination by slope
|
|
US11452738B2
(en)
|
2019-01-04 |
2022-09-27 |
Empirico Inc. |
Treatment of thymic stromal lymphopoietin (TSLP) related diseases by inhibition of long-form TSLP transcripts
|
|
CA3128233A1
(en)
|
2019-02-14 |
2020-08-20 |
Amgen Inc. |
Systems and methods for preparing a sample and performing a real-time assay of the sample
|
|
JP7530376B2
(ja)
|
2019-02-20 |
2024-08-07 |
アムジエン・インコーポレーテツド |
タンパク質の安定性を決定する方法
|
|
JP7570341B2
(ja)
|
2019-03-04 |
2024-10-21 |
アムジエン・インコーポレーテツド |
高分子量種のインビボでの可逆性
|
|
US12078701B2
(en)
|
2019-03-27 |
2024-09-03 |
Amgen Inc. |
Methods of fingerprinting therapeutic proteins via a two-dimensional (2D) nuclear magnetic resonance technique at natural abundance for formulated biopharmaceutical products
|
|
EP3958934B1
(en)
|
2019-04-24 |
2025-04-09 |
Amgen Inc. |
Syringe sterilization verification assemblies and methods
|
|
TWI917325B
(zh)
*
|
2019-06-04 |
2026-03-11 |
大陸商江蘇恆瑞醫藥股份有限公司 |
能結合胸腺基質淋巴細胞生成素的抗體及其應用
|
|
EP4517327A3
(en)
|
2019-06-05 |
2025-05-07 |
Amgen Inc. |
Methods of identifying attributes of therapeutic proteins
|
|
US12435131B2
(en)
|
2019-07-11 |
2025-10-07 |
Tavotek Biotherapeutics (Hong Kong) Limited |
Agents that interfere with thymic stromal lymphopoietin (TSLP)-receptor signaling
|
|
US20220273887A1
(en)
|
2019-08-23 |
2022-09-01 |
Amgen Inc. |
Drug delivery device with configurable needle shield engagement components and related methods
|
|
JP7331298B2
(ja)
*
|
2019-09-04 |
2023-08-23 |
ビオシオン インコーポレイテッド |
抗体結合ｔｓｌｐ及びその使用
|
|
KR20220069982A
(ko)
|
2019-09-26 |
2022-05-27 |
암젠 인크 |
항체 조성물의 생산 방법
|
|
EP4045515A4
(en)
|
2019-10-18 |
2023-10-18 |
The Regents Of The University Of Michigan |
BIOMATERIAL SENSOR SYSTEMS
|
|
UA129038C2
(uk)
*
|
2019-10-28 |
2024-12-25 |
Медіммуне Лімітед |
Сухий порошкоподібний склад антитіла, що зв'язує тимічний стромальний лімфопоетин (tslp)
|
|
CN114887053B
(zh)
*
|
2019-11-29 |
2026-04-24 |
康诺亚生物医药科技（成都）有限公司 |
一种tslp相关病症治疗剂的开发和应用
|
|
EP4047019A4
(en)
*
|
2019-12-13 |
2023-11-15 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Anti-tslp antibody and uses thereof
|
|
TW202140550A
(zh)
|
2020-01-29 |
2021-11-01 |
瑞士商諾華公司 |
使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法
|
|
CN111171150B
(zh)
*
|
2020-02-05 |
2020-12-08 |
北京智仁美博生物科技有限公司 |
抗人tslp抗体及其用途
|
|
EP4103605A1
(en)
|
2020-02-13 |
2022-12-21 |
Amgen Inc. |
Treatment of atopic dermatitis with anti-tslp antibody
|
|
CR20220457A
(es)
|
2020-02-13 |
2023-01-09 |
Amgen Inc |
Formulaciones de anticuerpos anti-tslp humanos y métodos de tratamiento de una enfermedad inflamatoria
|
|
MX2022010120A
(es)
|
2020-02-18 |
2022-09-05 |
Amgen Inc |
Formulaciones de anticuerpos anti-tslp humanos y metodos de uso de los mismos.
|
|
CN111662379B
(zh)
*
|
2020-05-09 |
2021-03-02 |
江苏省疾病预防控制中心(江苏省公共卫生研究院) |
抗新型冠状病毒的抗体、制备方法和应用
|
|
CN116829177A
(zh)
*
|
2020-05-20 |
2023-09-29 |
纽约市哥伦比亚大学理事会 |
抗SARS-CoV-2的有效中和抗体及其生成和用途
|
|
CA3184184A1
(en)
*
|
2020-05-20 |
2021-11-25 |
The Trustees Of Columbia University In The City Of New York |
Potent neutralizing antibodies against sars-cov-2, generation and uses thereof
|
|
WO2021247892A1
(en)
|
2020-06-04 |
2021-12-09 |
Amgen Inc. |
Assessment of cleaning procedures of a biotherapeutic manufacturing process
|
|
JP7872263B2
(ja)
|
2020-09-18 |
2026-06-09 |
アムジエン・インコーポレーテツド |
ペプチドマッピング分析のための試料を処理する方法
|
|
US20240043501A1
(en)
|
2020-10-15 |
2024-02-08 |
Amgen Inc. |
Relative unpaired glycans in antibody production methods
|
|
EP4240747A1
(en)
|
2020-11-05 |
2023-09-13 |
Amgen Inc. |
Materials and methods for protein processing
|
|
CN114437212B
(zh)
*
|
2020-11-06 |
2023-03-14 |
上海麦济生物技术有限公司 |
抗人胸腺基质淋巴细胞生成素抗体及其制备方法和应用
|
|
WO2022117079A1
(zh)
*
|
2020-12-03 |
2022-06-09 |
江苏恒瑞医药股份有限公司 |
结合胸腺基质淋巴细胞生成素的抗体及其应用
|
|
CN113501878B
(zh)
|
2021-02-03 |
2022-12-02 |
北京智仁美博生物科技有限公司 |
针对人tslp的多种抗体及其用途
|
|
WO2022166739A1
(en)
*
|
2021-02-04 |
2022-08-11 |
Staidson (Beijing) Biopharmaceuticals Co., Ltd. |
Antibodies specifically recognizing thymic stromal lymphopoietin and uses thereof
|
|
KR20230175245A
(ko)
|
2021-04-23 |
2023-12-29 |
암젠 인크 |
변형된 항-tslp 항체
|
|
US20240190951A1
(en)
|
2021-04-23 |
2024-06-13 |
Amgen Inc. |
Anti-tslp antibody compositions and uses thereof
|
|
BR112023024278A2
(pt)
|
2021-05-21 |
2024-01-30 |
Amgen Inc |
Método de otimizar uma receita de enchimento para um recipiente de fármacos
|
|
CA3217029A1
(en)
*
|
2021-05-30 |
2022-12-08 |
Biolojic Design Ltd. |
Engineered dual binding antibodies and uses thereof
|
|
CN113069543B
(zh)
*
|
2021-06-07 |
2021-08-06 |
迈威(上海)生物科技股份有限公司 |
包含抗胸腺基质淋巴细胞生成素的单克隆抗体的液体组合物
|
|
AU2022289365A1
(en)
|
2021-06-07 |
2023-12-14 |
Amgen Inc. |
Using fucosidase to control afucosylation level of glycosylated proteins
|
|
CN113683694B
(zh)
|
2021-09-03 |
2022-05-13 |
江苏荃信生物医药股份有限公司 |
一种抗人tslp单克隆抗体及其应用
|
|
JP2024537100A
(ja)
|
2021-10-05 |
2024-10-10 |
アムジエン・インコーポレーテツド |
Ｆｃガンマ受容体ＩＩ結合、及びグリカン含量
|
|
WO2023070948A1
(zh)
*
|
2021-11-01 |
2023-05-04 |
江苏荃信生物医药股份有限公司 |
包含抗人胸腺基质淋巴细胞生成素(tslp)单克隆抗体的浓缩溶液的制备方法及液体制剂
|
|
AU2022388727A1
(en)
|
2021-11-09 |
2024-05-16 |
Amgen Inc. |
Production of therapeutic proteins
|
|
CN117209604B
(zh)
*
|
2021-12-02 |
2024-03-22 |
北京东方百泰生物科技股份有限公司 |
一种抗tslp的单克隆抗体、其抗原结合片段及其应用
|
|
CN114369654B
(zh)
*
|
2021-12-21 |
2023-11-07 |
广州市妇女儿童医疗中心 |
川崎病的生物标志物及其应用
|
|
CA3244178A1
(en)
*
|
2021-12-24 |
2023-06-29 |
Inmagene Pte. Ltd. |
NEW ANTI-TSLP ANTIBODY
|
|
IL315262A
(en)
*
|
2022-03-03 |
2024-10-01 |
Pfizer |
Multiple specific antibodies related to IL-4, IL-13 and/or TSLP and their uses
|
|
WO2023215725A1
(en)
|
2022-05-02 |
2023-11-09 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
US12110324B2
(en)
|
2022-07-22 |
2024-10-08 |
Flagship Pioneering Innovations Vi, Llc |
Antigen binding molecules targeting thymic stromal lymphopoietin (TSLP)
|
|
CN118580343B
(zh)
*
|
2022-10-21 |
2025-08-19 |
珠海泰诺麦博制药股份有限公司 |
抗人巨细胞病毒抗体及其用途
|
|
TW202426485A
(zh)
|
2022-10-26 |
2024-07-01 |
美商安進公司 |
抗ｔｓｌｐ抗體組成物及其用途
|
|
TW202448501A
(zh)
|
2023-02-02 |
2024-12-16 |
美商麥迪紐有限責任公司 |
用抗ｔｓｌｐ抗體治療慢性鼻竇炎
|
|
IL323448A
(en)
*
|
2023-02-23 |
2025-12-01 |
Sichuan Kelun Biotech Biopharmaceutical Co Ltd |
Monoclonal antibody preparation targeting tslp
|
|
JP2026516670A
(ja)
|
2023-04-20 |
2026-05-26 |
アムジエン・インコーポレーテツド |
相対的な不対グリカン含有量を決定する方法
|
|
WO2024238877A1
(en)
|
2023-05-18 |
2024-11-21 |
Medimmune, Llc |
Treatment of corticosteroid dependent asthma with anti-tslp antibody
|
|
CN121311767A
(zh)
|
2023-06-14 |
2026-01-09 |
百时美施贵宝公司 |
糖蛋白的近实时唾液酸定量
|
|
EP4731663A2
(en)
*
|
2023-06-22 |
2026-04-29 |
Paragon Therapeutics, Inc. |
Antibodies that bind interleukin 13 and tslp or tslpr and methods of use
|
|
CN121443639A
(zh)
*
|
2023-06-22 |
2026-01-30 |
派拉冈医疗公司 |
结合tslp和tslpr的抗体及其使用方法
|
|
AU2024325342A1
(en)
|
2023-08-14 |
2026-02-26 |
Amgen Inc. |
Methods for reducing yellow color
|
|
AR133647A1
(es)
|
2023-08-25 |
2025-10-22 |
Proteologix Us Inc |
Constructos de anticuerpos multiespecíficos anti-il-13 y usos de los mismos
|
|
AR134101A1
(es)
*
|
2023-10-12 |
2025-12-03 |
Innovent Biologics Suzhou Co Ltd |
Anticuerpos anti-tslp y usos de los mismos
|
|
WO2025101602A1
(en)
|
2023-11-07 |
2025-05-15 |
Amgen Inc. |
Methods of analyzing amino acid content of a therapeutic protein
|
|
WO2025101820A1
(en)
|
2023-11-08 |
2025-05-15 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
AU2024385129A1
(en)
|
2023-11-22 |
2026-06-11 |
The United Bio-Technology (Hengqin) Co., Ltd. |
ANTI-IL-4Rα ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND BISPECIFIC ANTIBODY AND USE THEREOF
|
|
CN122295363A
(zh)
|
2023-11-22 |
2026-06-26 |
上海华奥泰生物药业股份有限公司 |
靶向tslp的抗原结合蛋白及应用
|
|
IL330343A
(en)
|
2024-01-05 |
2026-08-01 |
Medimmune Llc |
Treatment of chronic obstructive pulmonary disease using an anti-TSLP antibody
|
|
WO2025221247A1
(en)
|
2024-04-17 |
2025-10-23 |
Amgen Inc. |
Treatment of eosinophilic esophagitis with anti-tslp antibody
|
|
WO2025255028A1
(en)
|
2024-06-03 |
2025-12-11 |
Amgen Inc. |
High-throughput liquid chromatography-mass spectrometry-based peptide mapping
|
|
WO2025264860A2
(en)
|
2024-06-18 |
2025-12-26 |
Yale University |
Methods of treating post-covid airway disease
|
|
WO2025265071A1
(en)
*
|
2024-06-21 |
2025-12-26 |
Paragon Therapeutics, Inc. |
Antibodies that bind tslp and methods of use
|
|
WO2026030152A1
(en)
|
2024-07-29 |
2026-02-05 |
Amgen Inc. |
System and method for assessing transferability of a fill recipe
|
|
WO2026036112A1
(en)
*
|
2024-08-09 |
2026-02-12 |
Paragon Therapeutics, Inc. |
Compositions and methods comprising combinations of tslp and interleukin 4 receptor alpha antibodies
|
|
WO2026067826A1
(zh)
*
|
2024-09-30 |
2026-04-02 |
深圳市小分子新药创新中心有限公司 |
抗tslp单域抗体及其衍生物
|
|
WO2026086808A1
(zh)
*
|
2024-10-22 |
2026-04-30 |
海南先声药业有限公司 |
抗tslp抗体及其应用
|
|
WO2026090253A1
(en)
|
2024-10-23 |
2026-04-30 |
Amgen Inc. |
Methods of determining glycan pairing content
|
|
WO2026136851A1
(en)
|
2024-12-20 |
2026-06-25 |
Amgen Inc. |
Methods of diethylenetriaminepentaacetic acid (dtpa) quantification
|